Distinct roles of TNF-related apoptosis-inducing ligand (TRAIL) in viral and bacterial infections: from pathogenesis to pathogen clearance
- 4 March 2016
- journal article
- review article
- Published by Springer Science and Business Media LLC in Inflammation Research
- Vol. 65 (6), 427-437
- https://doi.org/10.1007/s00011-016-0934-1
Abstract
Introduction Apoptotic death of different cells observed during infection is thought to limit overwhelming inflammation in response to microbial challenge. However, the underlying apoptotic death mechanisms have not been well defined. Tumor necrosis factor (TNF) related apoptosis-inducing ligand (TRAIL) is a type II transmembrane protein belonging to the TNF superfamily, which is involved not only in tumor growth suppression but in infection control and also in the regulation of both innate and adaptive immune responses. Findings In this review, we have summarized data of recent studies on the influence of the TRAIL/TRAIL receptor (TRAIL-R) system on the development of viral and bacterial infections. TRAIL may have a dual function in the immune system being able to kill infected cells and also to participate in the pathogenesis of multiple infections. Moreover, many pathogens have evolved mechanisms to manipulate TRAIL signaling thus increasing pathogen replication. Conclusion Present data highlight an essential role for the TRAIL/TRAIL-R system in the regulation and modulation of apoptosis and show that TRAIL has distinct roles in pathogenesis and pathogen elimination. Knowledge of the factors that determine whether TRAIL is helpful or harmful supposes its potential therapeutic implications that are only beginning to be explored.Keywords
Funding Information
- National Science Fund, Ministry of Education and Science, Bulgaria (B01/6)
This publication has 112 references indexed in Scilit:
- TNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in miceThe Journal of Experimental Medicine, 2012
- Autophagy in the control and pathogenesis of viral infectionCurrent Opinion in Virology, 2011
- The death-promoting molecule tumour necrosis factor-related apoptosis inducing ligand (TRAIL) is not required for the development of peripheral lymphopenia or granuloma necrosis during infection with virulentMycobacterium aviumClinical and Experimental Immunology, 2011
- Type I interferon: friend or foe?The Journal of Experimental Medicine, 2010
- Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?Nature Reviews Microbiology, 2010
- Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumorsAnnals Of Oncology, 2009
- Gene expression profiling of dengue infected human primary cells identifies secreted mediators in vivoJournal of Medical Virology, 2009
- Following TRAIL’s path in the immune systemImmunology, 2009
- Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligandThe Journal of Experimental Medicine, 2008
- Antigen-Loading Compartments for Major Histocompatibility Complex Class II Molecules Continuously Receive Input from AutophagosomesImmunity, 2007